cobaltous chloride has been researched along with Heart Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Y; Jing, Q; Mei, Z; Song, H; Tang, Y; Wu, H; Yan, B; Yan, C; Zhang, X | 1 |
| Ajibade, T; Akinrinde, AS; Asenuga, E; Omobowale, O; Oyagbemi, A | 1 |
| Liu, F; Liu, YK; Tao, R; Xu, H; Yin, J | 1 |
3 other study(ies) available for cobaltous chloride and Heart Diseases
| Article | Year |
|---|---|
FGF21-FGFR1 controls mitochondrial homeostasis in cardiomyocytes by modulating the degradation of OPA1.
Topics: Animals; Fibroblast Growth Factors; Heart Diseases; Homeostasis; Mice; Mice, Knockout; Myocytes, Cardiac | 2023 |
Protective effects of kolaviron and gallic acid against cobalt-chloride-induced cardiorenal dysfunction via suppression of oxidative stress and activation of the ERK signaling pathway.
Topics: Acute Kidney Injury; Animals; Antioxidants; Cobalt; Drug Therapy, Combination; Flavonoids; Gallic Acid; Garcinia kola; Heart Diseases; Male; MAP Kinase Signaling System; Oxidative Stress; Plant Extracts; Protective Agents; Rats; Rats, Wistar; Seeds | 2016 |
Effects of serum cobalt ion concentration on the liver, kidney and heart in mice.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cobalt; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Diseases; Hepatocytes; Joint Prosthesis; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred ICR; Microscopy, Electron; Myocytes, Cardiac | 2010 |